Impact of Protein Formulations on the Stimulation of Muscle Protein Synthesis
ConditionNutrition
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19-40
SponsorVitaKey Inc.
About this trial
The overall objective of this study is to determine the effects of ingesting protein that slowly releases amino acids into the blood vs. a control product on how our muscles regulate the synthesis of new proteins, termed muscle protein synthesis (MPS), in healthy volunteers.
Eligibility criteria
Qualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
- Control Protein then Extended Release Nutritional Protein
- Extended Release Protein then Control Nutritional Protein
Treatment groups
20 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
VitaKey Inc.
Lead sponsor
United States Department of Defense (DOD)
Collaborator
Biofortis Clinical Research, Inc.
Collaborator
Source ClinicalTrials.gov